Dr. Marco Grenningloh
Bis 2022, EMEA IIS Trial Manager Oncology and Hematology, Janssen Cilag GmbH
Neuss, Deutschland
Werdegang
Berufserfahrung von Marco Grenningloh
Bis heute 2 Jahre und 4 Monate, seit Juni 2022
Global Trial Leader Hematology/Oncology
Janssen-Cilag GmbH, Johnson & Johnson
2 Jahre und 4 Monate, Feb. 2020 - Mai 2022
EMEA IIS Trial Manager Oncology and Hematology
Janssen Cilag GmbH
1 Jahr und 1 Monat, Feb. 2019 - Feb. 2020
EMEA IIS Trial Manager Oncology and Hematology for Janssen Cilag
Docs
11 Monate, Juli 2016 - Mai 2017
Senior Director Client Services
Accelovance
Accelovance is an award-winning CRO focused on optimizing the clinical conduct of Phase I–IV programs. With therapeutic expertise in oncology, vaccine, and general medicine; Accelovance provides a full complement of CRO services; operates a Clinical Engagement Solution specializing in recruitment, retention, and surveillance; and has a subsidiary (Optimal Research) that is a US site management organization.
1 Jahr und 8 Monate, Nov. 2014 - Juni 2016
Chief Operating Officer
THERAMetrics Holding AG
THERAMetrics holding AG is the parent company of a global tech-based contract research and development organization. The company, listed at the SIX Swiss Exchange, provides regulatory consulting, pharmacovigilance and marketing services as well as operational services for clinical trials (throughout Phase I – IV).
7 Jahre und 9 Monate, 2006 - Sep. 2013
Chief Operating Officer
ikfe-cro
2005 - 2007
Consultant Clinical Research
Cordis
2004 - 2006
Projekt Manager
Clinical Trial Operations
2002 - 2004
Projekt Manager
ikfe
2001 - 2002
Laborleiter
Cilian
Ausbildung von Marco Grenningloh
Biologie
WWU Münster
Zellbiologie, Biotechnologie
Sprachen
Deutsch
Muttersprache
Englisch
Gut
Niederländisch
Fließend